UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Common osteoporosis drug associated with increased rates of depression and anxiety

Scientific reports, 2021-12, Vol.11 (1), p.23956-23956, Article 23956

2021

Volltextzugriff (PDF)

Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis

Scientific reports, 2019-02, Vol.9 (1), p.2282, Article 2282

2019

Volltextzugriff (PDF)

Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database

Scientific reports, 2021-03, Vol.11 (1), p.5997-9, Article 5997

2021

Volltextzugriff (PDF)

Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System

Frontiers in psychiatry, 2024-06, Vol.15, p.1414622

2024

Volltextzugriff (PDF)

Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data

Scientific reports, 2023-06, Vol.13 (1), p.10448-10448, Article 10448

2023

Volltextzugriff (PDF)

Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events

PloS one, 2022-02, Vol.17 (2), p.e0263402

2022

Volltextzugriff (PDF)

Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites

Scientific reports, 2020-07, Vol.10 (1), p.12851, Article 12851

2020

Volltextzugriff (PDF)

Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data

Scientific reports, 2021-08, Vol.11 (1), p.17324-17324, Article 17324

2021

Volltextzugriff (PDF)

Co-Occurring Infections in Cancer Patients Treated with Checkpoint Inhibitors Significantly Increase the Risk of Immune-Related Adverse Events

Cancers, 2024-08, Vol.16 (16), p.2820

2024

Volltextzugriff (PDF)

Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety

Scientific reports, 2021-12, Vol.11 (1), p.24173-24173, Article 24173

2021

Volltextzugriff (PDF)

Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports

Scientific reports, 2020-11, Vol.10 (1), p.19199, Article 19199

2020

Volltextzugriff (PDF)

How can proton pump inhibitors damage central and peripheral nervous systems?

Neural regeneration research, 2020-11, Vol.15 (11), p.2041-2042

2020

Volltextzugriff (PDF)

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database

Frontiers in psychiatry, 2022-01, Vol.12, p.824288-824288

2022

Volltextzugriff (PDF)

Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis

JMIRx med, 2024-05, Vol.5, p.e55976-e55976

2024

Volltextzugriff (PDF)

Authors' Response to Peer Reviews of "Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis"

JMIRx med, 2024-05, Vol.5, p.e58273-e58273

2024

Volltextzugriff (PDF)

Depression Events Associated with Proton-Pump Inhibitors in Postmarketing Drug Surveillance Data

Pharmacoepidemiology, 2023-08, Vol.2 (3), p.272-282

2023

Volltextzugriff (PDF)

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Scientific reports, 2017-05, Vol.7 (1), p.1450-5, Article 1450

2017

Volltextzugriff (PDF)

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system

Frontiers in psychiatry, 2023-05, Vol.14, p.1149766-1149766

2023

Volltextzugriff (PDF)

Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain

PloS one, 2018-04, Vol.13 (4), p.e0195521-e0195521

2018

Volltextzugriff (PDF)

Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Scientific reports, 2017-12, Vol.7 (1), p.17268-1, Article 17268

2017

Volltextzugriff (PDF)

Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids

Scientific reports, 2019-08, Vol.9 (1), p.12490-10, Article 12490

2019

Volltextzugriff (PDF)

Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory

Scientific reports, 2019-11, Vol.9 (1), p.17280-10, Article 17280

2019

Volltextzugriff (PDF)

Divergent mechanisms for regulating growth and development after imaginal disc damage in the tobacco hornworm, Manduca sexta

Journal of experimental biology, 2019-10, Vol.222 (Pt 20)

2019

Volltextzugriff (PDF)

How can botulinum toxin help with depression?

TheScienceBreaker, 2021-09, Vol.7 (3)

2021

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Humans
(12)
Multidisciplinary Sciences
(12)
Science & Technology - Other Topics
(12)
Adverse Events
(7)
Female
(7)
Male
(7)
Life Sciences & Biomedicine
(5)
Mental Depression
(5)
Middle Aged
(5)
Antidepressants
(4)
Clinical Trials
(4)
Mdma
(4)
Statistical Analysis
(4)
United States - Epidemiology
(4)
United States Food And Drug Administration
(4)
Adult
(3)
Adverse Drug Reaction Reporting Systems
(3)
Aged
(3)
Antidepressive Agents - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Common osteoporosis drug associated with increased rates of depression and anxiety

Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis

Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database

Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System

Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data

Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events

Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites

Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data

Co-Occurring Infections in Cancer Patients Treated with Checkpoint Inhibitors Significantly Increase the Risk of Immune-Related Adverse Events

Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety

Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports

How can proton pump inhibitors damage central and peripheral nervous systems?

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database

Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis

Authors' Response to Peer Reviews of "Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis"

Depression Events Associated with Proton-Pump Inhibitors in Postmarketing Drug Surveillance Data

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system

Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain

Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids

Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory

Divergent mechanisms for regulating growth and development after imaginal disc damage in the tobacco hornworm, Manduca sexta

How can botulinum toxin help with depression?

Suchergebnisse filtern